BMAP-28(1-18)

General Information


DRACP ID  DRACP03722

Peptide Name   BMAP-28(1-18)

Sequence  GGLRSLGRKILRAWKKYG

Sequence Length  18

UniProt ID  P54229 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  2NDC 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C94H159N31O21

Absent amino acids  CDEFHMNPQTV

Common amino acids  G

Mass  236290

Pl  12.27

Basic residues  6

Acidic residues  0

Hydrophobic residues  6

Net charge  6

Boman Index  -3737

Hydrophobicity  -67.22

Aliphatic Index  92.22

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  411.18

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells

Doi Not available

Year  2014

Literature 2

Pubmed ID 30336202

Title  Structural insight into the mechanism of action of antimicrobial peptide BMAP-28(1-18) and its analogue mutBMAP18

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11938

DRACP is developed by Dr.Zheng's team.